UK patents law change will make conducting pharmaceutical clinical trials more attractive but clear legislative drafting is needed
This article was originally published in SRA
Executive Summary
The UK government's decision to amend the Patents Act 1977 is a step in the right direction, but clear legislative drafting is needed for the change to really achieve what’s intended, say Phil Bilney and Beatriz San Martin.